Breaking News, Promotions & Moves

Halozyme Therapeutics, Inc.

H. Michael Shepard, Ph.D., has joined Halozyme Therapeutics as vice president, discovery research.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

H. Michael Shepard, Ph.D., has joined Halozyme Therapeutics as vice president, discovery research. Dr. Shepard is a recipient of numerous biotechnology patents and scientific awards for his contributions to the development of innovative therapies. He has more than 25 years of experience in the biotechnology industry. At Genentech, Dr. Shepard led the team that discovered the breast cancer drug, Herceptin, which was designed to attack HER2 positive breast cancers. In 2007, Dr. Shepard shared the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters